ASIA-PACIFIC VACCINE EXCELLENCE AWARDS (AVEA) 2023
The Asia-Pacific Vaccine Excellence Awards (AVEA) 2023 exists to recognize the Asian vaccine manufacturing community and the achievements it has made over the past year. The industry has displayed resilience and innovation in the face of the COVID pandemic and the needs of the vaccine rollout, and continues with R&D excellence. The purpose of AVEA2023 is to recognize the outstanding achievements of vaccine & supply chain experts, organizations, and the newest technologies in Asia. Featuring top vaccine industry leaders, along with the latest advances in technologies and best practices in R&D and manufacturing, the Asia Pacific Vaccine Excellence Award applauds extraordinary leaders & trendsetters of today and inspires the innovators of tomorrow.
The Awards Ceremony will be held in conjunction with the 5th Annual Vaccines World Asia Congress 2023 Physical Conference, which will be held from 28th – 29th November 2023 at Sands Convention Center, Singapore.
How does it work?
The Asia-Pacific Vaccine Excellence Awards 2023, organized by IMAPAC, invites nominations from the vibrant vaccine community to recognize exemplary achievements in various categories related to vaccine excellence. With the participation of industry experts and professionals, the top 5 entries in each category are shortlisted based on nominations and assessments. The ultimate winner in each category is determined through 100% public or vaccine community voting, ensuring a fair and transparent selection process. Join us in celebrating the outstanding contributions and breakthroughs that have shaped the landscape of vaccine excellence in the Asia-Pacific region at AVEA2023.
TIMELINE OF AWARDS
Criteria to win the awards
THE FOR THE ASIA-PACIFIC VACCINE EXCELLENCE AWRDS 2023 (AVEA 2023) SELECTION PROCESS INVLOVES FOLLOWING STEPS :
Nomination and assessment: We invite nominations from the vaccine industry and assess the submissions based on their merits and adherence to the award criteria.
- Shortlisting of top entries: The top 5-7 entries in each award category are shortlisted based on the number of nominations and a comprehensive evaluation of their achievements, contributions, and advancements in the field of vaccines.
Award winner determination: From the shortlisted entries, the final award winner in each category will be determined through a 100% voting process conducted within the vaccine community. The voting results reflect the collective opinion of industry experts, professionals, and stakeholders.
Recognition of winners: The companies receiving the highest number of votes in their respective categories will be announced as the winners of the Asia-Pacific Vaccine Excellence Awards 2023, acknowledging their outstanding contributions and excellence in the vaccine industry.